Pay in 4 interest-free payments of $7.21 Learn more
)
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Even without concurrent medications, unexplained hypoglycemia symptoms should be reported and investigated
Researchers have investigated whether dual activation of GIP and GLP-1 receptors produces effects that differ from single-agonist research compounds, particularly in the context of preclinical models of metabolic dysfunction
Specifications Scientific Name CJC-1295 (Modified GRF 1-29) + Ipamorelin: Two-Peptide Research Blend CAS Number 446036-97-1 / 170851-70-4 Molecular Formula CJC-1295 CHNO Ipamorelin CHNO Molecular Weight Blend: CJC-1295 (no DAC) 3,367.9 g/mol Ipamorelin 711.9 g/mol Physical Form Lyophilized powder Purity Coming Soon Storage & Handling Storage Store the lyophilized powder at 20C in a standard laboratory freezer, protected from light, moisture, and heat
10.1161/circresaha.121.319059 7 DayC
Who can purchase this product
Researchers studying the GH/IGF-1 axis for applications in muscle metabolism, bone density, connective tissue repair, and aging use this combination to achieve robust, sustained IGF-1 elevation in research models
